OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 196
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 196
Showing 51-75 of 196 citing articles:
A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review)
Liming Zheng, Xingyue Chen, Li Zhang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 13
Liming Zheng, Xingyue Chen, Li Zhang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 13
RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Lipid Metabolism as a Potential Target of Liver Cancer
Kangze Wu, Feizhuan Lin
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 327-346
Open Access | Times Cited: 4
Kangze Wu, Feizhuan Lin
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 327-346
Open Access | Times Cited: 4
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification
Haoyu Wang, Mu Xu, Tong Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 4
Haoyu Wang, Mu Xu, Tong Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 4
Group IV Bimetallic MOFs Engineering Enhanced Metabolic Profiles Co‐Predict Liposarcoma Recognition and Classification
Heyuhan Zhang, Ping Tao, Hanxing Tong, et al.
Small Methods (2025)
Closed Access
Heyuhan Zhang, Ping Tao, Hanxing Tong, et al.
Small Methods (2025)
Closed Access
DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis
Kornelius Schulze, Tim Rose, Lorenz Adlung, et al.
JHEP Reports (2025), pp. 101340-101340
Open Access
Kornelius Schulze, Tim Rose, Lorenz Adlung, et al.
JHEP Reports (2025), pp. 101340-101340
Open Access
Biosocial Determinants of Health Among Patients with Chronic Liver Disease and Liver Cancer
Tagari Samanta, Jun Hyoung Park, Benny Abraham Kaipparettu
Cancers (2025) Vol. 17, Iss. 5, pp. 844-844
Open Access
Tagari Samanta, Jun Hyoung Park, Benny Abraham Kaipparettu
Cancers (2025) Vol. 17, Iss. 5, pp. 844-844
Open Access
Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis
Linzhuo Huang, Rui Xu, Siyu Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Linzhuo Huang, Rui Xu, Siyu Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Discovery of targeting USP10-mediated proline metabolism arrangement to inhibit hepatocellular carcinoma progression
Yinze Han, Weili Kong, Qi‐Xin Shang, et al.
Biochemical Pharmacology (2025), pp. 116904-116904
Closed Access
Yinze Han, Weili Kong, Qi‐Xin Shang, et al.
Biochemical Pharmacology (2025), pp. 116904-116904
Closed Access
Metabolism, sex, and what lies beyond the scalpel in MASLD
Zong‐Long Li, Yue Tang, De-Long Qin, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Zong‐Long Li, Yue Tang, De-Long Qin, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
Leticia Colyn, Marina Bárcena‐Varela, Gloria Álvarez‐Sola, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2380-2396
Closed Access | Times Cited: 37
Leticia Colyn, Marina Bárcena‐Varela, Gloria Álvarez‐Sola, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2380-2396
Closed Access | Times Cited: 37
Molecular Targets in Cholangiocarcinoma
Colm J. O’Rourke, Patricia Muñoz-Garrido, Jesper B. Andersen
Hepatology (2020) Vol. 73, Iss. S1, pp. 62-74
Closed Access | Times Cited: 33
Colm J. O’Rourke, Patricia Muñoz-Garrido, Jesper B. Andersen
Hepatology (2020) Vol. 73, Iss. S1, pp. 62-74
Closed Access | Times Cited: 33
Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
Tao Zhang, Yingli Nie, Jian Gu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Tao Zhang, Yingli Nie, Jian Gu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Metabolic Reprogramming and Renal Fibrosis
Xiaoyu Zhu, Lili Jiang, Mengtuan Long, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 31
Xiaoyu Zhu, Lili Jiang, Mengtuan Long, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 31
Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma
Tengfei Liu, Junming Yu, Chao Ge, et al.
Cancer Letters (2022) Vol. 536, pp. 215642-215642
Closed Access | Times Cited: 20
Tengfei Liu, Junming Yu, Chao Ge, et al.
Cancer Letters (2022) Vol. 536, pp. 215642-215642
Closed Access | Times Cited: 20
Bioimaging agents based on redox-active transition metal complexes
Shan-Shan Xue, Yingbo Pan, Wei Pan, et al.
Chemical Science (2022) Vol. 13, Iss. 33, pp. 9468-9484
Open Access | Times Cited: 19
Shan-Shan Xue, Yingbo Pan, Wei Pan, et al.
Chemical Science (2022) Vol. 13, Iss. 33, pp. 9468-9484
Open Access | Times Cited: 19
Machine learning-empowered cis-diol metabolic fingerprinting enables precise diagnosis of primary liver cancer
Pengfei Li, Shuxin Xu, Yanjie Han, et al.
Chemical Science (2023) Vol. 14, Iss. 10, pp. 2553-2561
Open Access | Times Cited: 11
Pengfei Li, Shuxin Xu, Yanjie Han, et al.
Chemical Science (2023) Vol. 14, Iss. 10, pp. 2553-2561
Open Access | Times Cited: 11
Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer
Racheal O. Ogbodu, Bianca Nitzsche, Andi Ma, et al.
Journal of Photochemistry and Photobiology B Biology (2020) Vol. 208, pp. 111915-111915
Open Access | Times Cited: 27
Racheal O. Ogbodu, Bianca Nitzsche, Andi Ma, et al.
Journal of Photochemistry and Photobiology B Biology (2020) Vol. 208, pp. 111915-111915
Open Access | Times Cited: 27
Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma
Keun Soo Ahn, Daniel R. O’Brien, Yong‐Hoon Kim, et al.
Liver Cancer (2021) Vol. 10, Iss. 6, pp. 593-605
Open Access | Times Cited: 25
Keun Soo Ahn, Daniel R. O’Brien, Yong‐Hoon Kim, et al.
Liver Cancer (2021) Vol. 10, Iss. 6, pp. 593-605
Open Access | Times Cited: 25
The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
Suliman Khan, Deyu Zhang, Jiyu Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Suliman Khan, Deyu Zhang, Jiyu Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Cullin‐associated and neddylation‐dissociated 1 regulate reprogramming of lipid metabolism through SKP1‐Cullin‐1‐F‐boxFBXO11‐mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma
Hao Zhang, Peng Xia, Zhangshuo Yang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Hao Zhang, Peng Xia, Zhangshuo Yang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma
Yaqin Zhao, Huabing Tan, Xiaoyu Zhang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 9
Yaqin Zhao, Huabing Tan, Xiaoyu Zhang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 9
